Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2/3 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 36Breast 35Thoracic 19CNS 18Genitourinary 12Head & Neck 11Dermatologic 10Other hematologic neoplasm 9Lymphoid 7Gynecologic 7Sarcoma 6Tumor-Agnostic 4Myeloid 4Endocrine 4Classical hematology 3Plasma cell 2Other 2Other solid neoplasm 1Other neoplasm 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Sodium Chloride × Tumor-Agnostic × Clear all
NCT01369641 2025-05-16

The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy

Thomas Jefferson University

Phase NA Terminated
1 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT04741880 2021-07-30

ELSA

Instituto Nacional de Cancer, Brazil

Phase 2/3 Unknown
66 enrolled
Tumor-Agnostic

Neoplasms

NCT02604225 2020-05-11

TRUSB

University of Sydney

Phase 3 Completed
420 enrolled
Tumor-Agnostic

Neoplasms

NCT01242293 2016-02-23

Intrapartum Hydration

HaEmek Medical Center, Israel

Phase NA Completed
300 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡